WST
West Pharmaceutical Services Inc
370.40$
-0.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 39.5% | 39.7% | 37.4% | 39.9% | 56.2% | 45.2% | 49.2% | 52.6% | 53.1% | 50.6% | 42.2% | 46.3% | |
| 15.3% | 16.2% | 11.8% | 12.7% | 21.2% | 18.8% | 22.0% | 23.0% | 24.7% | 22.3% | 13.3% | 18.5% | |
| 15.3% | 16.2% | 11.8% | 12.7% | 21.2% | 18.8% | 22.0% | 23.0% | 24.7% | 22.3% | 13.3% | 18.5% | |
| 10.7% | 10.7% | 11.7% | 13.6% | 18.1% | 13.6% | 13.8% | 14.8% | 14.0% | 13.4% | 15.2% | 13.5% | |
| 10.9% | 10.7% | 11.6% | 11.6% | 13.5% | 10.1% | 11.5% | 11.4% | 11.5% | 11.4% | 10.3% | 10.4% | |
| 42.2% | 42.5% | 45.3% | 45.9% | 51.6% | 35.8% | 33.8% | 31.9% | 32.0% | 39.5% | 47.1% | 43.2% | |
| 6.5% | 6.2% | 6.0% | 5.8% | 6.6% | 4.6% | 4.0% | 3.3% | 3.0% | 2.8% | 2.9% | 2.6% | |
| 2.5% | 2.2% | 1.4% | 1.2% | 1.3% | 1.3% | 1.1% | 0.7% | 0.5% | 0.4% | 0.3% | 0.2% | |
| 42.7% | 39.6% | 34.9% | 10.6% | 36.6% | 32.8% | 33.6% | 29.5% | 25.8% | 24.8% | 26.4% | 25.6% | |
| 15.1% | 18.5% | 14.0% | 15.0% | 17.8% | 14.6% | 18.0% | 17.9% | 14.3% | 17.5% | 15.1% | 15.3% | |
| 1.6% | 4.1% | 0.1% | 5.5% | 0.0% | 0.5% | 0.4% | 1.6% | 0.5% | 4.0% | 0.5% | 0.5% | |
| 6.2% | 7.1% | 7.1% | 7.4% | 8.2% | 6.7% | 7.6% | 7.0% | 6.0% | 6.3% | 6.6% | 5.9% | |
| 18.5% | 13.5% | 13.2% | 10.6% | 12.3% | 10.9% | 9.1% | 6.3% | 5.7% | 1.9% | 5.6% | 4.7% | |
| 57.3% | 60.4% | 65.1% | 89.4% | 87.7% | 67.2% | 66.4% | 70.5% | 74.2% | 75.2% | 73.6% | 74.4% | |
| 54.0% | 56.9% | 62.4% | 63.2% | 85.0% | 66.2% | 66.1% | 74.1% | 82.6% | 92.0% | 108.6% | 102.5% | |
| 4.4% | 4.4% | 4.4% | 4.1% | 4.7% | 3.2% | 2.7% | 2.3% | 2.1% | 2.0% | 2.0% | 1.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.